SmartZyme's Series A Round

SmartZyme raised a round of funding on October 27, 2015. Investors include OrbiMed Advisors.

SmartZyme is a privately held biopharmaceutical company focused on its Provolution technological platform for protein design and engineering, in accordance with industry specifications. The company ai…

Articles about SmartZyme's Series A Round: